Comparing available treatments for pollen-induced allergic rhinitis in children

References

• Schuler IV CF, Montejo JM. Allergic rhinitis in children and adolescents. Immunol Allergy Clin North Am. 2021;41(4):613–625.
   PubMedGoogle Scholar
• Xie ZJ, Guan K, Yin J. Advances in the clinical and mechanism research of pollen induced seasonal allergic asthma. Am J Clin Exp Immunol. 2019;8(1):1–8.
   PubMed Web of Science ®Google Scholar
• Licari A, Castagnoli R, Denicolò CF, et al. The nose and the lung: united airway disease? Front Pediatr. 2017;5:44.
   PubMed Web of Science ®Google Scholar
• Klain A, Indolfi C, Dinardo G, et al. United airway disease. Acta Biomed. 2021;92(S7):e2021526.
   PubMedGoogle Scholar
• Carlson G, Coop C. Pollen food allergy syndrome (PFAS): a review of current available literature. Ann Allergy Asthma Immunol. 2019;123(4):359–365.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Schünemann HJ, Togias A, et al., Next-generation allergic rhinitis and its impact on asthma (ARIA) guidelines for allergic rhinitis based on grading of recommendations assessment, development and evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70–80.e3.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6(1):95.
   PubMed Web of Science ®Google Scholar
• Nur Husna SM, Tan HT, Md Shukri N, et al. Allergic rhinitis: a clinical and pathophysiological overview. Front Med (Lausanne). 2022;9:874114.
   PubMedGoogle Scholar
• Calamelli E, Liotti L, Beghetti I, et al. Component-resolved diagnosis in food allergies. Medicina (Kaunas). 2019;55(8):498.
   Google Scholar
• Martelli A, Calvani M, Foiadelli T, et al. Component resolved diagnosis and risk assessment in food allergy. Acta Biomed. 2021;92(S7):e2021528.
   PubMedGoogle Scholar
• Scadding GK, Smith PK, Blaiss M, et al. Allergic rhinitis in childhood and the new EUFOREA algorithm. Front Allergy. 2021;2:706589.
   PubMedGoogle Scholar
• Emeryk A, Emeryk-Maksymiuk J, Janeczek K. New guidelines for the treatment of seasonal allergic rhinitis. Postepy Dermatol Alergolog. 2019;36(3):255–260
   PubMed Web of Science ®Google Scholar
• Velentza L, Maridaki Z, Blana E, et al., Antihistamines in the management of pediatric allergic rhinitis: a systematic review. Paediatr Drugs. 2020;22(6):673–683.
   PubMedGoogle Scholar
• Fitzsimons R, van der Poel LA, Thornhill W, et al. Antihistamine use in children. Arch Dis Child Educ Pract Ed. 2015;100(3):122–131.
   PubMed Web of Science ®Google Scholar
• Church MK, Church DS. Pharmacology of antihistamines. Indian J Dermatol. 2013;58(3):219–224.
   PubMedGoogle Scholar
• Shah SR, Nayak A, Ratner P, et al. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults. Clin Ther. 2009;31(1):99–107.
   PubMedGoogle Scholar
• Yonekura S, Okamoto Y, Sakurai D, et al. Efficacy of desloratadine and levocetirizine in patients with cedar pollen-induced allergic rhinitis: a randomized, double-blind study. Int Arch Allergy Immunol. 2019;180(4):274–283.
   PubMedGoogle Scholar
• Parisi GF, Leonardi S, Ciprandi G, et al. Cetirizine use in childhood: an update of a friendly 30-year drug. Clin Mol Allergy. 2020;18(1):2.
   PubMedGoogle Scholar
• Kawauchi H, Yanai K, Wang DY, et al. Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. Int J Mol Sci. 2019;20(1):213.
   PubMed Web of Science ®Google Scholar
• Wheatley LM, Togias A. Clinical practice. Allergic rhinitis. N Engl J Med. 2015;372(5):456–463
   PubMed Web of Science ®Google Scholar
• May JR, Dolen WK. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39(12):2410–2419.
   PubMedGoogle Scholar
• Parisi GF, Leonardi S, Ciprandi G, et al., Antihistamines in children and adolescents: a practical update. Allergol Immunopathol (Madr). 2020;48(6):753–762.
   PubMedGoogle Scholar
• Juel-Berg N, Darling P, Bolvig J, et al. Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2017;31(1):19–28.
   PubMedGoogle Scholar
• Yamamoto H, Yonekura S, Sakurai D, et al. Using an environmental challenge chamber, comparing nasal steroid with antihistamine in prophylactic treatment against pollinosis. Allergy Asthma Proc. 2012;33(5):397–403.
   PubMedGoogle Scholar
• Zhang M, Ni JZ, Cheng L. Safety of intranasal corticosteroids for allergic rhinitis in children. Expert Opin Drug Saf. 2022. (in press). 1–8. DOI:https://doi.org/10.1080/14740338.2022.2046731.
   Google Scholar
• Daley-Yates PT, Larenas-Linnemann D, Bhargave C, et al. Intranasal corticosteroids: topical potency, systemic activity and therapeutic index. J Asthma Allergy. 2021;14:1093–1104.
   PubMed Web of Science ®Google Scholar
• Chitsuthipakorn W, Hoang MP, Kanjanawasee D, et al. Combined medical therapy in the treatment of allergic rhinitis: systematic review and meta-analyses. Int Forum Allergy Rhinol. 2022. (in press). DOI:https://doi.org/10.1002/alr.23015.
   Google Scholar
• Hoang MP, Chitsuthipakorn W, Seresirikachorn K, et al. As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis. Rhinology. 2022. (in press). DOI:https://doi.org/10.4193/Rhin21.355.
   Google Scholar
• Phinyo P, Wongsa C, Sompornrattanaphan M, et al. As-needed versus regular intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis. Asian Pac J Allergy Immunol. 2022. (in press). DOI:https://doi.org/10.12932/AP-091121-1269.
   Google Scholar
• Daley-Yates PT, Larenas-Linnemann D, Bhargave C, et al. Intranasal corticosteroids: topical potency, systemic activity and therapeutic index. J Asthma Allergy. 2021;14:1093–1104.
   PubMed Web of Science ®Google Scholar
• Pfaar O, Bousquet J, Durham SR, et al. One hundred and ten years of allergen immunotherapy: a journey from empiric observation to evidence. Allergy. 2022;77(2):454–468.
   PubMedGoogle Scholar
• Bousquet J, Pfaar O, Agache I, et al., ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy. Clin Transl Allergy. 2021;11(4):e12014.
   PubMedGoogle Scholar
• de Silva D, Rodríguez Del Río P, de Jong NW, et al. Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2022;77(6):1852–1862.
   Google Scholar
• Dhulipalla S. Ragweed sublingual immunotherapy (SLIT) tablets in allergic rhinoconjunctivitis: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2022;279(6):2765–2775.
   PubMedGoogle Scholar
• Matricardi PM, Kuna P, Panetta V, et al. Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses. J Allergy Clin Immunol. 2011;128(4):791–799.e6.
   PubMed Web of Science ®Google Scholar
• Devillier P, Dreyfus JF, Demoly P, et al. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Med. 2014;12(1):71.
   PubMed Web of Science ®Google Scholar
• De Filippo M, Votto M, Caminiti L, et al. Safety of allergen-specific immunotherapy in children. Pediatr Allergy Immunol. 2022;33(27):27–30.
   PubMedGoogle Scholar
• Masieri S, Bachert C, Ojeda P, et al. Allergen immunotherapy management during vaccinations: an international survey. World Allergy Organ J. 2021;14(11):100601.
   PubMedGoogle Scholar
• Cardinale F, Ciprandi G, Barberi S, et al., Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital J Pediatr. 2020;46(1):84.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Tosca MA. Under-prescription of allergen-immunotherapy: why is it important to prescribe it in childhood instead? Immunotherapy. 2021;13(5):359–361.
   PubMedGoogle Scholar
• Phomakay V, Tankersley M. Allergen immunotherapy in young children. Curr Allergy Asthma Rep. 2022. (in press). DOI:https://doi.org/10.1007/s11882-022-01035-0.
   Google Scholar
• Cazzola M, Anapurapu S, Page CP. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis. Pulm Pharmacol Ther. 2012;25(1):62–68.
   PubMed Web of Science ®Google Scholar
• Roßberg S, Keller T, Icke K, et al. Orally applied bacterial lysate in infants at risk for atopy does not prevent atopic dermatitis, allergic rhinitis, asthma or allergic sensitization at school age: follow-up of a randomized trial. Allergy. 2020;75(8):2020–2025.
   PubMedGoogle Scholar
• Li C, Zhou H, Zhang W, et al. Bacterial lysate treatment in allergic disease: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2021;32(8):1813–1823.
   PubMedGoogle Scholar
• Janeczek K, Emeryk A, Rachel M, et al. Polyvalent mechanical bacterial lysate administration improves the clinical course of grass pollen-induced allergic rhinitis in children: a randomized controlled trial. J Allergy Clin Immunol Pract. 2021;9(1):453–462.
   PubMedGoogle Scholar
• Janeczek KP, Emeryk A, Rapiejko P. Effect of polyvalent bacterial lysate on the clinical course of pollen allergic rhinitis in children. Adv Dermatol Allergol Postępy Dermatol Alergol. 2019;36(4):504–505
   PubMed Web of Science ®Google Scholar
• Rolinck-Werninghaus C, Keil T, Kopp M, et al. Specific IgE serum concentration is associated with symptom severity in children with seasonal allergic rhinitis. Allergy. 2008;63(10):1339–1344.
   PubMedGoogle Scholar
• Licari A, Marseglia GL, Caimmi S, et al. Omalizumab in children. Paediatr Drugs. 2014;16(6):491–502.
   PubMed Web of Science ®Google Scholar
• Bez C, Schubert R, Kopp M, et al. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis. Clin Exp Allergy. 2004;34(7):1079–1085.
   PubMedGoogle Scholar
• Kuehr J, Brauburger J, Zielen S, et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol. 2002;109(2):274–280.
   PubMed Web of Science ®Google Scholar
• Rolinck-Werninghaus C, Hamelmann E, Keil T, et al. The co-seasonal application of anti-IgE after pre-seasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Allergy. 2004;59(9):973–979.
   PubMed Web of Science ®Google Scholar
• Kopp MV, Hamelmann E, Bendiks M, et al. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy. Pediatr Allergy Immunol. 2013;24(5):427–433.
   PubMed Web of Science ®Google Scholar
• Kamin W, Kopp MV, Erdnuess F, et al. Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously. Pediatr Allergy Immunol. 2010;21(1 Pt 2):e160–e165.
   PubMed Web of Science ®Google Scholar
• Strauss RA. Nasal cromolyn in the treatment of rhinitis. J Allergy Clin Immunol Pract. 2020;8(8):2841–2842.
   PubMedGoogle Scholar
• Mainardi T, Kapoor S, Bielory L. Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol. 2009;123(2):283–294.
   PubMedGoogle Scholar
• Aragona SE, Ciprandi G. Probiotics for the management of upper respiratory diseases. J Biol Reg Hom Ag. 2020;34(S 1):1–4.
   PubMedGoogle Scholar
• Chen N, Liu F, Gao Q, et al. A meta-analysis of probiotic for the treatment of allergic airway diseases in children and adolescents. Am J Rhinol Allergy. 2022;36(4):480–490. (in press).
   Google Scholar
• Yan S, Ai S, Huang L, et al. Systematic review and meta-analysis of probiotics in the treatment of allergicrhinitis. Allergol Immunopathol (Madr). 2022;50(3):24–37.
   PubMedGoogle Scholar
• Yan S, Ai S, Huang L, et al. Vitamin D supplementation in pregnant women or infants for preventing allergic diseases: a systematic review and meta-analysis of randomized controlled trials. Chin Med J (Engl). 2022;135(3):276–284.
   PubMedGoogle Scholar
• Linton S, Burrows AG, Hossenbaccus L, et al. Future of allergic rhinitis management. Ann Allergy Asthma Immunol. 2021;127(2):183–190.
   PubMedGoogle Scholar
• Pellow J, Nolte A, Temane A, et al. Health supplements for allergic rhinitis: a mixed-methods systematic review. Complement Ther Med. 2020;51:102425.
   PubMedGoogle Scholar
• Del Giudice M M, Maiello N, Capristo C, et al. Resveratrol plus carboxymethyl-ß-glucan reduces nasal symptoms in children with pollen-induced allergic rhinitis. Curr Med Res Op. 2014;30(10):1931–1935.
   PubMedGoogle Scholar
• Liew KY, Kamise NI, Ong HM, et al. Anti-Allergic properties of propolis: evidence from preclinical and clinical studies. Front Pharmacol. 2022;12:785371.
   PubMedGoogle Scholar
• Miraglia Del Giudice M, Indolfi C, Capasso M, et al. Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma. Ital J Pediatr. 2017;43(1):25.
   PubMedGoogle Scholar
• Dennis-Wall JC, Culpepper T, Nieves C Jr, et al. Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial. Am J Clin Nutr. 2017;105(3):758–767.
   PubMed Web of Science ®Google Scholar
• Jerzynska J, Stelmach W, Rychlik B, et al. The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy Asthma Proc. 2016;37(2):105–114.
   PubMedGoogle Scholar
• Marseglia GL, Licari A, Ciprandi G. A polycentric, randomized, double-blind, parallel-group, placebo-controlled study on Lertal®, a multicomponent nutraceutical, as add-on treatment in children with allergic rhinoconjunctivitis: phase I during active treatment. J Biol Reg. 2019;33:617–622.
   Google Scholar
• Marseglia GL, Licari A, Leonardi S, et al. A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II. Ital J Ped. 2019;45(1):84.
   PubMedGoogle Scholar